Summit Trail Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183K Buy
16,941
+5,841
+53% +$50K ﹤0.01% 1381
2025
Q4
$67.8K Buy
+11,100
New +$66.3K ﹤0.01% 1298
2018
Q1
Sell
-320
Closed -$8K 1356
2017
Q4
$8K Buy
+320
New +$6.63K ﹤0.01% 1286

Other funds holding PTEN

Summit Trail Advisors's PTEN Position: Q1 2026 in Review

Summit Trail Advisors increased its Patterson-UTI (PTEN) stake by 53% in Q1 2026, buying an estimated $50K and bringing the position to 16,941 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Summit Trail Advisors first reported a position in PTEN in Q4 2017 and has held it in 3 quarters since. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Summit Trail Advisors held 16,941 shares of Patterson-UTI worth $183K as of Q1 2026.
  • Summit Trail Advisors bought 5,841 Patterson-UTI shares in Q1 2026, an estimated $50K.
  • Patterson-UTI made up ﹤0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #1381 holding.
  • Summit Trail Advisors first reported a position in Patterson-UTI in Q4 2017 and has held it in 3 quarters since.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.